Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Imraldi 40 mg solution for injection in pre-filled pen (0.8ml)

Active Ingredient:
adalimumab
Company:  
Biogen Biosimilars See contact details
ATC code: 
L04AB04
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.
{info_black}
Last updated on emc: 12 Jan 2023
{pdf} View or print the patient leaflet as PDF
Biogen Biosimilars
Company image
Address
5 Foundation Park, Roxborough Way, Maidenhead, Berkshire, SL6 3UD, UK
Telephone
+44 (0) 203 608 8622
Medical Information Direct Line
+44 (0) 203 608 8622
Medical Information e-mail
[email protected]
WWW
https://www.biogen.uk.com